The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression
Open accessAbstract
Translational regulation plays a critical role in the control of cell growth and proliferation. A key player in translational control is eIF4E, the mRNA 5′ cap-binding protein. Aberrant expression of eIF4E promotes tumorigenesis and has been implicated in cancer development and progression. The activity of eIF4E is dysregulated in cancer. Regulation of eIF4E is partly achieved through phosphorylation. However, the physiological significance of eIF4E phosphorylation in mammals is not clear. Here, we show that knock-in mice expressing a nonphosphorylatable form of eIF4E are resistant to tumorigenesis in a prostate cancer model. By using a genome-wide analysis of translated mRNAs, we show that the phosphorylation of eIF4E is required for translational up-regulation of several proteins implicated in tumorigenesis. Accordingly, increased phospho-eIF4E levels correlate with disease progression in patients with prostate cancer. Our findings establish eIF4E phosphorylation as a critical event in tumorigenesis. These findings raise the possibility that chemical compounds that prevent the phosphorylation of eIF4E could act as anticancer drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform
Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pander, A., & Chinnaiyan, A. M. (2004) · Neoplasia · doi:10.1016/s1476-5586(04)80047-2 · Cited by 3,612
eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation
Gingras, A.-C., Raught, B., & Sonenberg, N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.913 · Cited by 2,121
Self-citationThoreen, C. C., Kang, S. A., Chang, J. W., Liu, Q., Zhang, J., Gao, Y., Reichling, L. J., Sim, T., Sabatini, D. M., & Gray, N. S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900301200 · Cited by 1,803
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
Lapointe, J., Li, C., Higgins, J. P., van de Rijn, M., Bair, E., Montgomery, K., Ferrari, M., Egevad, L., Rayford, W., Bergerheim, U., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304146101 · Cited by 1,292
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Angela Nieto, M., et al. (2005) · Nature · doi:10.1038/nature03688 · Cited by 1,284
McNeal, J. E., Redwine, E. A., Freiha, F. S., & Stamey, T. A. (1988) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198812000-00001 · Cited by 1,182
Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
Feldman, M. E., Apsel, B., Uotila, A., Loewith, R., Knight, Z. A., Ruggero, D., & Shokat, K. M. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000038 · Cited by 1,082
Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap
Lazaris-Karatzas, A., Montine, K. S., & Sonenberg, N. (1990) · Nature · doi:10.1038/345544a0 · Cited by 956
Self-citationSurvival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H.-G., Stanchina, E. D., Fridman, J. S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 951
Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2
Waskiewicz, A. J. (1997) · The EMBO Journal · doi:10.1093/emboj/16.8.1909 · Cited by 947
Integrative molecular concept modeling of prostate cancer progression
Tomlins, S. A., Mehra, R., Rhodes, D. R., Cao, X., Wang, L., Dhanasekaran, S. M., Kalyana-Sundaram, S., Wei, J. T., Rubin, M. A., Pienta, K. J., et al. (2007) · Nature Genetics · doi:10.1038/ng1935 · Cited by 922
Varambally, S., Yu, J., Laxman, B., Rhodes, D. R., Mehra, R., Tomlins, S. A., Shah, R. B., Chandran, U., Monzon, F. A., Becich, M. J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.001 · Cited by 800
eIF-4E expression and its role in malignancies and metastases
De Benedetti, A., & Graff, J. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207545 · Cited by 728
Pten Dose Dictates Cancer Progression in the Prostate
Trotman, L. C., Niki, M., Dotan, Z. A., Koutcher, J. A., Di Cristofano, A., Xiao, A., Khoo, A. S., Roy-Burman, P., Greenberg, N. M., Dyke, T. V., et al. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000059 · Cited by 676
Self-citationFukunaga, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.8.1921 · Cited by 663
Human eukaryotic translation initiation factor 4G (eIF4G) recruits Mnk1 to phosphorylate eIF4E
Pyronnet, S. (1999) · The EMBO Journal · doi:10.1093/emboj/18.1.270 · Cited by 639
mTOR, translation initiation and cancer
Mamane, Y., Petroulakis, E., LeBacquer, O., & Sonenberg, N. (2006) · Oncogene · doi:10.1038/sj.onc.1209888 · Cited by 607 · cited 1×
“via the phosphorylation of the suppressor 4E-BPs by mammalian target of rapamycin complex 1 (mTORC1) (1, 14).”
BackgroundSelf-citationThe translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis
Ruggero, D., Montanaro, L., Ma, L., Xu, W., Londei, P., Cordon-Cardo, C., & Pandolfi, P. P. (2004) · Nature Medicine · doi:10.1038/nm1042 · Cited by 586
Self-citationUeda, T., Watanabe-Fukunaga, R., Fukuyama, H., Nagata, S., & Fukunaga, R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.15.6539-6549.2004 · Cited by 507
Dissecting eIF4E action in tumorigenesis
Wendel, H.-G., Silva, R. L. A., Malina, A., Mills, J. R., Zhu, H., Ueda, T., Watanabe-Fukunaga, R., Fukunaga, R., Teruya-Feldstein, J., Pelletier, J., et al. (2007) · Genes & Development · doi:10.1101/gad.1604407 · Cited by 487 · cited 1×
“eIF4E phosphorylation at serine 209 by MNK1/2 promotes its transformation activity (11, 12).”
BackgroundWaskiewicz, A. J., Johnson, J. C., Penn, B., Mahalingam, M., Kimball, S. R., & Cooper, J. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1871 · Cited by 469
Kinkade, C. W., Castillo-Martin, M., Puzio-Kuter, A., Yan, J., Foster, T. H., Gao, H., Sun, Y., Ouyang, X., Gerald, W. L., Cordon-Cardo, C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34764 · Cited by 391
Van Damme, J., Proost, P., Lenaerts, J. P., & Opdenakker, G. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.1.59 · Cited by 371
Avdulov, S., Li, S., Michalek, V., Burrichter, D., Peterson, M., Perlman, D. M., Manivel, J. C., Sonenberg, N., Yee, D., Bitterman, P. B., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.024 · Cited by 340
Self-citationLe Bacquer, O., Petroulakis, E., Paglialunga, S., Poulin, F., Richard, D., Cianflone, K., & Sonenberg, N. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29528 · Cited by 334
Self-citationLoberg, R. D., Ying, C., Craig, M., Day, L. L., Sargent, E., Neeley, C., Wojno, K., Snyder, L. A., Yan, L., & Pienta, K. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1286 · Cited by 333
Does phosphorylation of the cap‐binding protein eIF4E play a role in translation initiation?
Scheper, G. C., & Proud, C. G. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03291.x · Cited by 308
COMPARATIVE ASPECTS OF DEVELOPMENT AND STRUCTURE IN THE PROSTATE.
PRICE, D. (1963) · PubMed · Cited by 258
Topisirovic, I., Ruiz-Gutierrez, M., & Borden, K. L. B. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2677 · Cited by 257
Phosphorylation of Eukaryotic Initiation Factor 4E Markedly Reduces Its Affinity for Capped mRNA
Scheper, G. C., van Kollenburg, B., Hu, J., Luo, Y., Goss, D. J., & Proud, C. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103607200 · Cited by 255
Singh, S., Singh, U. P., Grizzle, W. E., & Lillard, J. W. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700181 · Cited by 251
Gingras, A.-C., Raught, B., & Sonenberg, N. (2004) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-18930-2_11 · Cited by 246
Self-citationTargets and mechanisms for the regulation of translation in malignant transformation
Clemens, M. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207544 · Cited by 223
Graff, J. R., Konicek, B. W., Lynch, R. L., Dumstorf, C. A., Dowless, M. S., McNulty, A. M., Parsons, S. H., Brail, L. H., Colligan, B. M., Koop, J. W., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3472 · Cited by 202
Prostatic Intraepithelial Neoplasia in Genetically Engineered Mice
Park, J.-H., Walls, J. E., Galvez, J. J., Kim, M., Abate-Shen, C., Shen, M. M., & Cardiff, R. D. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64228-9 · Cited by 172
Zuberek, J., Wysłouch‐Cieszyńska, A., Niedźwiecka-Kornaś, A., Dadlez, M., Stȩpiński, J., Augustyniak, W., Gingras, A., ZHANG, Z., Burley, S. K., Sonenberg, N., et al. (2003) · RNA · doi:10.1261/rna.2133403 · Cited by 161
Self-citationA Destructive Cascade Mediated by CCL2 Facilitates Prostate Cancer Growth in Bone
Li, X., Loberg, R. D., Liao, J., Chi, Y., Snyder, L. A., Pienta, K. J., & McCauley, L. K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2164 · Cited by 153
Bianchini, A., Loiarro, M., Bielli, P., Busà, R., Paronetto, M. P., Loreni, F., Geremia, R., & Sette, C. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn221 · Cited by 148
Page, C. L., Koumakpayi, I. H., Alam‐Fahmy, M., Mes‐Masson, A., & Fred Saad, C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603184 · Cited by 89
Self-citationMNK kinases regulate multiple TLR pathways and innate proinflammatory cytokines in macrophages
Rowlett, R. M., Chrestensen, C. A., Nyce, M. R., Harp, M. G., Pelo, J. W., Cominelli, F., Ernst, P. B., Pizarro, T. T., Sturgill, T. W., & Worthington, M. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00077.2007 · Cited by 80
Slepenkov, S. V., Darżynkiewicz, E., & Rhoads, R. E. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601653200 · Cited by 71
SURVIVAL OF PATIENTS WITH HORMONE REFRACTORY PROSTATE CANCER IN THE PROSTATE SPECIFIC ANTIGEN ERA
Oefelein, M. G., Agarwal, P. K., & Resnick, M. I. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000118294.88852.cd · Cited by 63
Apoptosis Measurement by Annexin V Staining
Miller, E. P. (2003) · Humana Press eBooks · doi:10.1385/1-59259-406-9:191 · Cited by 54
Proteases as modulators of tumor–stromal interaction: Primary tumors to bone metastases
Wilson, T. J., & Singh, R. K. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.11.001 · Cited by 53
Flynn, A., & Proud, C. G. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00040.x · Cited by 42
Couto, S. S., Cao, M., Duarte, P. C. X., Banach-Petrosky, W. A., Wang, S., Romanienko, P. J., Wu, H., Cardiff, R. D., Abate-Shen, C. T., & Cunha, G. R. (2009) · Differentiation · doi:10.1016/j.diff.2008.09.010 · Cited by 39
Diallo, J., Aldejmah, A., Filali-Mouhim, A., Péant, B., Fahmy, M. A., Koumakpayi, I. H., Sircar, K., Bégin, L. R., Mes‐Masson, A., & Fred Saad, C. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1224 · Cited by 36
Self-citation
Cited by
Mammalian MAPK Signal Transduction Pathways Activated by Stress and Inflammation: A 10-Year Update
Kyriakis, J. M., & Avruch, J. (2012) · Physiological Reviews · doi:10.1152/physrev.00028.2011 · Cited by 1,466
The translational landscape of mTOR signalling steers cancer initiation and metastasis
Hsieh, A. C., Liu, Y., Edlind, M. P., Ingolia, N. T., Janes, M. R., Sher, A., Shi, E. Y., Stumpf, C. R., Christensen, C., Bonham, M. J., et al. (2012) · Nature · doi:10.1038/nature10912 · Cited by 1,313
ERK signalling: A master regulator of cell behaviour, life and fate
Lavoie, H., Gagnon, J., & Therrien, M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0255-7 · Cited by 1,185
Targeting the translation machinery in cancer
Bhat, M., Robichaud, N., Hulea, L., Sonenberg, N., Pelletier, J., & Topisirovic, I. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4505 · Cited by 799
Self-citationRNA-Binding Proteins in Cancer: Old Players and New Actors
Pereira, B., Billaud, M., & Almeida, R. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.05.003 · Cited by 773
Metadata
- Authors
- Furic, L., Rong, L., Larsson, O., Koumakpayi, I. H., Yoshida, K., Brueschke, A., Petroulakis, E., Robichaud, N., Pollak, M., Gaboury, L. A., Pandolfi, P. P., Saad, F., & Sonenberg, N.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2010-08-02
- Volume
- 107
- Issue
- 32
- Pages
- 14134-14139
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1986308117
- Cited by
- 519
- References
- 47
- FWCI
- 10.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.